Atea Pharmaceuticals, Inc. (AVIR) Q3 2023 Earnings Call Transcript
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Jonae Barnes – SVP, IR & Corporate
Stocks making the biggest moves midday: Warner Bros., Occidental Petroleum, Rivian, Toast and more
Check out the companies making headlines in midday trading. Upstart Holdings — Stock in the artificial intelligence lending platform tumbled more than 27% after
Amazon adds a new reason to get and keep Prime: member discounts on health-care services
Amazon (AMZN) said on Wednesday that it’s offering Prime members a discount on its new health-care service — another perk that should help bring
KORU Medical Systems, Inc. 2023 Q3 – Results – Earnings Call Presentation (NASDAQ:KRMD)
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands
18-year-old got hired as a Google engineer—his dad shares his No. 1 parenting rule: I take a ‘hands off approach’
Stanley Zhong isn’t your typical 18-year-old. He’s not your typical Google software engineer, either. Zhong graduated from Gunn High School in Palo Alto, California,
Social Security’s trust funds may run out in 2034. These changes may help
The clock is ticking for Congress to shore up Social Security benefits. The latest projections from Social Security’s actuaries show the program’s trust funds
US Physical Therapy, Inc. (USPH) Q3 2023 Earnings Call Transcript
US Physical Therapy, Inc. (NYSE:USPH) Q3 2023 Earnings Conference Call November 8, 2023 10:30 AM ET Company Participants Christopher Reading – President, CEO &
This S&P 500 stock has the highest return over the past 20 years—it’s not Apple or Tesla
Investors, stop us if you’ve heard this one before: Past performance is no guarantee of future results. It’s a good mantra to keep in
Eli Lilly receives approval for its weight-loss drug. But here’s what could boost the stock next
Shares of Eli Lilly (LLY) jumped Wednesday after the U.S. government gave the green light for the company’s blockbuster GLP-1 drug to be used
Amicus Therapeutics Inc. (FOLD) Q3 2023 Earnings Call Transcript
Amicus Therapeutics Inc. (NASDAQ:FOLD) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Andrew Faughnan – Vice President, Investor Relations
Most Read
